What about Th1/Th2 in cutaneous leishmaniasis vaccine discovery? - Wikidata - wikimedia - TriplyDB

What about Th1/Th2 in cutaneous leishmaniasis vaccine discovery?

What about Th1/Th2 in cutaneous leishmaniasis vaccine discovery?

http://www.wikidata.org/entity/Q36188736

about

Kinetoplastid Membrane Protein-11 as a Vaccine Candidate and a Virulence Factor in Leishmania Differences in immune responses against Leishmania induced by infection and by immunization with killed parasite antigen: implications for vaccine discovery Vaccines for the leishmaniases: proposals for a research agenda T-cell expression cloning of Porphyromonas gingivalis genes coding for T helper-biased immune responses during infection Babassu aqueous extract (BAE) as an adjuvant for T helper (Th)1-dependent immune responses in mice of a Th2 immune response-prone strain.Coadministration of the Three Antigenic Leishmania infantum Poly (A) Binding Proteins as a DNA Vaccine Induces Protection against Leishmania major Infection in BALB/c Mice Leishmania donovani whole cell antigen delivered with adjuvants protects against visceral leishmaniasis in vervet monkeys (Chlorocebus aethiops).Th1 biased response to a novel Porphyromonas gingivalis protein aggravates bone resorption caused by this oral pathogen Histopathological and immunohistochemical aspects of American cutaneous leishmaniasis before and after different treatments.Immune responses in DNA vaccine formulated with PMMA following immunization and after challenge with Leishmania major Identification of immunodominant Leishmania major antigenic markers of the early C57BL/6 and BALB/c mice infection stages.American cutaneous leishmaniasis in infancy and childhood.The role of Montanide ISA 70 as an adjuvant in immune responses against Leishmania major induced by thiol-specific antioxidant-based protein vaccine Induction of Immune Responses by DNA Vaccines Formulated with Dendrimer and Poly (Methyl Methacrylate) (PMMA) Nano-Adjuvants in BALB/c Mice Infected with Leishmania major.Cytokine expression in dogs with natural Leishmania infantum infection

P2860

Q26777203-DE47299C-B53C-4DCD-972E-B4C1BCBAB4C7 Q28077110-2F2A7A3D-0829-4D78-89E4-721AE13C44EF Q28741577-E088474F-2F59-4AD8-A762-ADF7D69016F1 Q33247526-D2C3AB65-3B1A-475D-8679-A3A169C52C78 Q33806434-EA9D5561-1D28-4EBF-B6D8-8148D5BF9E6D Q35587034-84310AC0-D6B7-4E85-8E5F-54AC7486BA1C Q36680084-8D274B40-E36E-4436-A422-C297E50C2837 Q36713642-E68DA33B-C8ED-465C-B1D5-9DDA11D0F26B Q36977741-80718649-A8F0-48DF-AB20-951FEEB7D990 Q37053209-DE3B1F85-3182-434D-986F-EDEFCEF90A8F Q38971667-CC323F07-40A1-44F2-A011-C0EED8DEE839 Q39336818-27DF7BE4-B0AE-49D7-A4EA-61D473799D98 Q41278156-F6C14935-ED3F-413E-9BD4-EA41DB46458A Q52659333-41942A22-5E52-4A61-9895-51EFF4651B21 Q56958576-00D3BB81-F2CC-4C49-9E47-C6998142492D

P2860

What about Th1/Th2 in cutaneous leishmaniasis vaccine discovery?

http://www.wikidata.org/entity/Q36188736

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

What about Th1/Th2 in cutaneous leishmaniasis vaccine discovery?

@ast

What about Th1/Th2 in cutaneous leishmaniasis vaccine discovery?

@en

type

label

What about Th1/Th2 in cutaneous leishmaniasis vaccine discovery?

@ast

What about Th1/Th2 in cutaneous leishmaniasis vaccine discovery?

@en

prefLabel

What about Th1/Th2 in cutaneous leishmaniasis vaccine discovery?

@ast

What about Th1/Th2 in cutaneous leishmaniasis vaccine discovery?

@en

P1433

Q36188736-7A473531-DAAF-4805-B2DA-5B41B36E5EC9

P1476

Q36188736-607FA076-3247-4B0A-9E95-5B7FE3642FEC

P2093

Q36188736-98C4EF02-99D9-44C7-9A9C-FB7095B0B11B

P2860

Q36188736-007AD164-BAE2-4F77-AA8E-D71759AADFBF

Q36188736-0CA3771B-4618-4F71-80A1-F5F666198AAD

Q36188736-0F7A370D-1AA8-444E-8132-D82A0D88D1E8

Q36188736-10D4D67E-2240-4F7C-917B-39AE3EB152C6

Q36188736-20D6FE84-BBBD-44CB-A89B-EF5AAE279785

Q36188736-285A8A6D-C98F-4BED-A931-3A05111793D0

Q36188736-30CC22CD-032F-4744-8077-297DBE623050

Q36188736-325CF75B-8F34-4B00-8A27-B0E45C6D335F

Q36188736-329D3D38-CCF2-489C-A0CD-1B34BFD8CA53

Q36188736-32C2980B-762C-448C-8155-1050C57FA249

P304

Q36188736-A9CDD82A-18A6-46DF-BD7F-B7C57FED24B1

P31

Q36188736-6DCCBB89-7986-4C69-BC6D-075BB2FADB96

P356

Q36188736-51BB6E6B-84E9-4247-B476-C449A46052DC

P407

Q36188736-6DC4FE7D-FC2A-47CB-BABB-2EC8EDA1036C

P433

Q36188736-21443D66-1340-450A-8071-31D1EE169FBF

P478

Q36188736-E02FB494-55CB-4AE5-840F-A8A57FEFD66C

P577

Q36188736-DCDFC782-52FF-4DED-AA1C-B651ADA14B42

P698

Q36188736-53D29CC9-7601-4024-9671-96FDA0D1D2C0

P356

S0100-879X2005000700001

P1433

Brazilian Journal of Medical and Biological Research

P1476

What about Th1/Th2 in cutaneous leishmaniasis vaccine discovery?

@en

P2093

A Campos-Neto

http://www.w3.org/2001/XMLSchema#string

P2860

Identification and characterization of T cell-stimulating antigens from Leishmania by CD4 T cell expression cloning.

T cell expression cloning of a Mycobacterium tuberculosis gene encoding a protective antigen associated with the early control of infection.

Cytokine patterns in the pathogenesis of human leishmaniasis.

Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease.

CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity.

Development of a leishmaniasis vaccine: the importance of MPL.

Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens

CD4+ effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major

Mice from a genetically resistant background lacking the interferon gamma receptor are susceptible to infection with Leishmania major but mount a polarized T helper cell 1-type CD4+ T cell response.

Cloning and expression of a Leishmania donovani gene instructed by a peptide isolated from major histocompatibility complex class II molecules of infected macrophages.

P304

979-984

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1590/S0100-879X2005000700001

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P577

2005-07-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16007269

http://www.w3.org/2001/XMLSchema#string